维普期刊资源整合服务平台（V6.5）

80篇 您的检索式：作者名="Chachoua A"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	A Phase Ⅱ trial of the epidermal growth factor receptor ( EGFR ) tyrosine kinase inhibitor OSI-774,following platinum-based chemotherapy,in patients (pts) with advanced, EGFR-expressing, non-small cell lung cancer (NSCLC)显示文摘	Perez-Soler R Chachoua A Huberman M	2001	Proc Am Soc Clin Oncol2001，20，31：	1
2	A phase Ⅱ trial of the epidermal growth factor recepror (EGFR) tyrosine kinase inhibitor OSI-774,following platinum-based chemotherapy,in patients (pts) with advanced,EGFR-expressing,non-small cell lung cancer (NSCLC)显示文摘	Perez-soler R chachoua A Huberman M	2001	Proc Am Soc Clin Oncol2001，21，：	1
3	Determi- nants of tumor response and sm'vival with erlotinib in pa- tients with non-small-cell lung cancer 显示文摘	Rrez-Soler R Chachoua A Hammond LA	2004	Clin Oncol2004，22，16：	1
4	Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer显示文摘	Perez-Soler R Chachoua A Hammond LA	2004	J Clin Oncol2004，22，16：	1
5	Determinants of tumor response and survival with erlotinib in patients with non small cell lung cancer 显示文摘	Perez Soler R Chachoua A Hammond LA	2004	J Clin Oncol2004，22，16：	1
6	Determinants of tumor response and survival with erlotinib in patients with non-small cell lung cancer 显示文摘	Perez Soler R Chachoua A Hammond LA	2004	J Clin Oncol2004，22，：	1
7	Determinants of tumor response and survival with erlotinib in patients with non- small -cell lung cancer 显示文摘	Perez - Soler R Chachoua A Hammond LA	2004	J Clin Oncol2004，22，：	1
8	Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer显示文摘	Perez SR Chachoua A Hammond LA	2004	J Clin Oncol2004，22，16：	1
9	Determinants of tumor response and survival with Erlotinib in patients with non-small cell lung cancer显示文摘	P e rez-Soler R Chachoua A Hammond LA	2004	J Clin Oncol2004，22，16：	1
10	Determinants of tumor response and survival with erlotinib in patients with non-- small-cell lung cancer显示文摘	Perez-Soler R Chachoua A Hammond LA	2004	J Clin Oncol2004，22，16：	1
11	Oxaliplatin with weekly bolus fuorouracil and low-dose leucovorin as first line therapy for patients with advanced colorectal cancer显示文摘	Hochster HS Chachoua A Speyer J	2003	J Clin Oncol2003，21，14：	1
12	Determinants of tumor response and survival with erlotinib in patients with no - small - cell lung cancer 显示文摘	Perez- Soler R Chachoua A Hammond L	2004	J Clin Oncol2004，22，16：	1
13	Determinants of tumor response and survival with erlotinib in patients with non-small cell lung cancer显示文摘	Petez-Soler R Chachoua A Hammond LA	2004	J Clin Oncol2004，22，：	1
14	Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer显示文摘	Perez-Soler R Chachoua A Hammond LA	2004	J din Oncol2004，22，16：	1
15	A phase Ⅱ trial of the epidermal growth factor tyrosine kinse in-hibitor OSI-774 following platinum-based chemotherapy in patients with advanced EGFR-expressing,non-small cell lung cancer 显示文摘	Prez-Soler R Chachoua A Huberman M	2001	Proc Am Soc Clin Oncol2001，20，3：	1
16	Determi- nants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer 显示文摘	Perez-Soler R Chachoua A Hammond LA	2004	J Clin Oncol2004，22，16：	1
17	Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first line therapy for patients with colorectal cancer显示文摘	Hochster H Chachoua A Speyer J	2003	J Clin Oncol2003，21，14：	1
18	Determinants of tumor -sponse and survival with erlotinib in patients with non- small-cell lung cancer显示文摘	Perez-Soler R Chachoua A Hammond LA	2004	J Clin Onco12004，22，16：	1
19	Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer显示文摘	PEREZ-SOLER R CHACHOUA A HAMMOND LA	2004	J Clin Oncol2004，22，16：	1
20	Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer显示文摘	Perez-Soler R Chachoua A Hammond LA	2004	J Clin Oncol2004，22，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示